Zentalis Pharmaceuticals, Inc. (ZNTL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

SA Transcripts 162.21K Followers Follow Zentalis Pharmaceuticals, Inc. ( ZNTL ) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 2:35 PM EDT Company Participants Julie Eastland - CEO, President & Director Ingmar Bruns - Chief Medical Officer Conference Call Participants Michael Ulz - Morgan Stanley, Research Division Presentation Michael Ulz Morgan Stanley, Research Division Good afternoon, everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, one of the biotech analysts here, and it's my pleasure to introduce the team from Zentalis. We have Julie Eastland, CEO, to my left, and to her left is Ingmar Bruns, CMO. And just a reminder, the format is a fireside talk. So if anyone in the audience has a question, please raise your hand and we'll try to address it in our discussion. But before we get started, I just need to read a quick disclosure. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com backslash research disclosures. If you have any questions please reach out to your Morgan Stanley sales representative. And with that, maybe I'll just hand it over to Julie for some brief introductory remarks, and then we can hop into Q&A. Julie Eastland CEO, President & Director Thanks, Michael. As always, we really appreciate the invite and the time. And just to go toe-to-toe for disclosures, since that seems to be the flavor, I would hate to be remiss in reminding the audience that we will be making estimates and forward-looking statements, and so there are risks and uncertainties associated with that. those and we encourage those listening to review our SEC filings. Now we both are squared away with our lawyers. Michael Ulz Morgan Stanley, Research Division We did our duty here. Yeah. Maybe you just want to give a brief introduction to Zentalis and